Risk of COVID-19 breakthrough infection and hospitalization in individuals with comorbidities-Reference-Cited by-同舟云学术

Risk of COVID-19 breakthrough infection and hospitalization in individuals with comorbidities

Published:2023-04 Issue:15 Volume:41 Page:2447-2455
ISSN:0264-410X
Container-title:Vaccine
language:en
Short-container-title:Vaccine

Author:

Smits Peter D.,Gratzl Samuel,Simonov Michael,Nachimuthu Senthil K.,Goodwin Cartwright Brianna M.,Wang Michael D.,Baker Charlotte^ORCID,Rodriguez Patricia,Bogiages Mackenzie^ORCID,Althouse Benjamin M.^ORCID,Stucky Nicholas L.^ORCID

Publisher

Elsevier BV

Subject

Infectious Diseases,Public Health, Environmental and Occupational Health,General Veterinary,General Immunology and Microbiology,Molecular Medicine

Reference62 articles.

1. Safety and efficacy of the BNT162b2 mRNA covid-19 vaccine;Polack;N Engl J Med,2020

2. Weiping Deng, Honghong Zhou, Shu Han, Melanie Ivarsson, Jacqueline Miller, and Tal Zaks. Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine;Baden;N Engl J Med,2021

3. Philip R Krause, Thomas R Fleming, Richard Peto, Ira M Longini, J Peter Figueroa, Jonathan A C Sterne, Alejandro Cravioto, Helen Rees, Julian P T Higgins, Isabelle Boutron, Hongchao Pan, Marion F Gruber, Narendra Arora, Fatema Kazi, Rogerio Gaspar, Soumya Swaminathan, Michael J Ryan, and Ana-Maria Henao-Restrepo. Considerations in boosting covid-19 vaccine immune responses. The Lancet, 398(10308):1377–1380, 2021. doi: 10.1016/s0140-6736(21)020 46-8.

4. Antibody response and variant cross-neutralization after sars-cov-2 breakthrough infection;Bates;JAMA,2022

5. Hospitalisation among vaccine breakthrough covid-19 infections;Juthani;Lancet,2021

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Incidence and risk factors of SARS-CoV-2 breakthrough infection in the early Omicron variant era among vaccinated and boosted individuals in Chicago;PLOS ONE;2024-08-05

2. Development and validation of a symbolic regression-based machine learning method to predict COVID-19 in-hospital mortality among vaccinated patients;Health and Technology;2024-05-24

3. Natural Killer Cells Do Not Attenuate a Mouse-Adapted SARS-CoV-2-Induced Disease in Rag2−/− Mice;Viruses;2024-04-15

4. Incidence and risk factors of omicron variant SARS-CoV-2 breakthrough infection among vaccinated and boosted individuals;2024-04-05

5. Factors associated with the worsening of COVID-19 symptoms among cohorts in community- or home-isolation care in southern Thailand;Frontiers in Public Health;2024-03-20